VIAL-TL1A-HLE

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug NameVIAL-TL1A-HLE
Drug Alias NameBB-TL1A-VIAL-HLEVIAL-TL1A-HLETL1A-HLE
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Tumor necrosis factor superfamily member 15
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBattery Bio Australia Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVial Australia Pty Ltd
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A